Literature DB >> 19451364

Bedside evaluation of thienopyridine antiplatelet therapy.

Matthew J Price1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19451364     DOI: 10.1161/CIRCULATIONAHA.107.696732

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  31 in total

1.  High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound study.

Authors:  Amala P Chirumamilla; Akiko Maehara; Gary S Mintz; Roxana Mehran; Sunil Kanwal; Giora Weisz; Ahmed Hassanin; Diaa Hakim; Ning Guo; Usman Baber; Robert Pyo; Jeffrey W Moses; Martin Fahy; Jason C Kovacic; George D Dangas
Journal:  JACC Cardiovasc Imaging       Date:  2012-05

Review 2.  State of the art of new P2Y12 antagonists.

Authors:  Marco Cattaneo; Gian Marco Podda
Journal:  Intern Emerg Med       Date:  2010-02-23       Impact factor: 3.397

Review 3.  Novel anti-platelet agents in acute coronary syndrome: mechanisms of action and opportunities to tailor therapy.

Authors:  Neha Quatromoni; Sony Tuteja; Daniel M Kolanksy; William H Matthai; Jay Giri
Journal:  Curr Atheroscler Rep       Date:  2015-05       Impact factor: 5.113

4.  Lower on-treatment platelet reactivity during everolimus-eluting stent implantation contributes to the resolution of post-procedural intra-stent thrombus: serial OCT observation in the PRASFIT-Elective study.

Authors:  Akihide Konishi; Masamichi Iwasaki; Toshiro Shinke; Hiromasa Otake; Masayuki Nakagawa; Hirotoshi Hariki; Tsuyoshi Osue; Takumi Inoue; Yu Taniguchi; Ryo Nishio; Hiroto Kinutani; Noritoshi Hiranuma; Masaru Kuroda; Ken-Ichi Hirata; Shigeru Saito; Masato Nakamura; Junya Shite; Takashi Akasaka
Journal:  Heart Vessels       Date:  2018-07-02       Impact factor: 2.037

5.  Platelet inhibition to target reperfusion injury trial: Rationale and study design.

Authors:  Heerajnarain Bulluck; Mervyn H H Chan; Jennifer A Bryant; Ping Chai; Ashish Chawla; Terrance S Chua; Yiu-Cho Chung; Gao Fei; Hee H Ho; Andrew F W Ho; Andrew J Hoe; Syed S Imran; Chi-Hang Lee; Swee H Lim; Boon W Liew; Patrick L Z Yun; Marcus O E Hock; Valeria Paradies; Matthew T Roe; Lynette Teo; Aaron S Wong; Evelyn Wong; Philip E Wong; Timothy Watson; Mark Y Chan; Jack W Tan; Derek J Hausenloy
Journal:  Clin Cardiol       Date:  2018-12-17       Impact factor: 2.882

6.  Utility of the Aspirin and P2Y12 Response Assays to Determine the Effect of Antiplatelet Agents on Platelet Reactivity in Traumatic Brain Injury.

Authors:  Phillip V Parry; Phillip A Choi; Joshua S Bauer; David M Panczykowski; Ava M Puccio; David O Okonkwo
Journal:  Neurosurgery       Date:  2017-01-01       Impact factor: 4.654

7.  Use of Aspirin and P2Y12 Response Assays in Detecting Reversal of Platelet Inhibition With Platelet Transfusion in Patients With Traumatic Brain Injury on Antiplatelet Therapy.

Authors:  Phillip A Choi; Phillip V Parry; Joshua S Bauer; Benjamin E Zusman; David M Panczykowski; Ava M Puccio; David O Okonkwo
Journal:  Neurosurgery       Date:  2017-01-01       Impact factor: 4.654

8.  Case report: use of thienopyridines in a patient with acquired idiopathic thrombotic thrombocytopenic purpura.

Authors:  Luca A Lotta; Ilaria Mancini; Giacomo Tuana; Khaled M Musallam; Flora Peyvandi
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

Review 9.  Platelet function monitoring and clopidogrel.

Authors:  Andrew R Harper; Matthew J Price
Journal:  Curr Cardiol Rep       Date:  2013-01       Impact factor: 2.931

10.  Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism.

Authors:  Desmond J Fitzgerald; Garret A Fitzgerald
Journal:  Circ Res       Date:  2013-01-04       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.